RESUMO
Anaemia is the most common nutritional problem in the world .In the outpatient department of National institute of Siddha the significant numbers of anaemia cases are reporting for treatment. As the part of partial completion of 1st year MD degree the investigator select the minor project to determine the data about prevalence of Paandu (Anaemia) in NIS OPD patients. This study includes 500 OPD patients. OPD patients in the age between 13-74 years were randomly selected daily (Systematic random sampling method). A pre-designed self-administrated questionnaire interview method is used for collecting data about the patients. Information on personal characteristics, socio economic status, diet, lab investigations, clinical profiles are obtained. The study results showed that the prevalence of anemia amongst patients reporting at NIS OPD were 45.6%. The mean haemoglobin concentration was 11.4g/dl in female and 12.8g/dl in male. Majority of female in reproductive age (15-49 years) had the highest prevalence of anemia. And the high proportion of microcytic hypochromic anaemia (22.2%) was founded in the selected samples which indicate that Iron deficiency was the main cause of anaemia. Effect of socio economic status on anemic patients reported in NIS also calculated according to ‘Modified Kuppusamy socio economic scale’ which results that patients belongs to the upper lower status (12.2%) are more prone to anemia. Therefore the results of this study can be used to design target interventions aimed at reducing the prevalence of anemia in NIS OPD and to help conduct the interactive educational programs for improve disease awareness in female patients especially. And further studies are needed for clarify prevalence and etiology of anaemia in school going children (Below 13 years) at NIS OPD.
RESUMO
Objective: The present pilot study was designed to evaluate the efficacy of Seenthil sarkarai, a Classical Siddha medicine in Moothirakiricharam (Urinary Tract Infection) patients. Method: This study was approved by IEC and registered in Clinical Trial Registry of India and was conducted at the National Institute of Siddha, Tambaram, Chennai, India. The investigator recruited 20 patients of both male and female with an inclusion and exclusion criteria. All the patients were treated with Seenthil Sarkarai at the dose level of 2 grams two times a day with warm water for 21 days. Dietary regimen was advised for the patients. Study outcome was studied with negative Urine culture and also based on the improvement in the reduction of Burning micturition, Frequency of micturition, Dysuria with fever, Foul smelling urine. Results: The symptoms such as burning micturition, persistent urge to urinate, foul smelling urine, and presence of bacteriuria reduced markedly within 21 days of duration. Out of 20 patients, 12 patients were completely relieved from the compliance of UTI with negative Urine culture. The symptoms of UTI were markedly reduced in remaining 8 patients. There were no adverse effect reported during the study and no recurrence of UTI was noticed in 12 patients who were completely cured. Conclusion: Results suggest that the trial drug Seenthil Sarkarai is effective and safe for the management of Moothirakiricharam (UTI) and in alleviating recurrences.
RESUMO
Mantha Sanni (Autism) is a Mukkuttra disease that is imbalance of all the three main fundamental principles of Vatham, Pitham and Kabam. Mantha Sanni is a neuro developmental disorder typically appearing in the first one and half years of life and characterised by impaired social and communication skills.. In the all over the world, the surveillance study identified 1 in 68 children suffering with ASD. In India, the prevalence ratio is 1:46. It is about 4.5 times more common among boys (1:48) than among girls (1:189). The higher prevalence rate was observed in the rural area. Socioeconomic status may be one of the fundamental indicators for ASD in India. Autism spectrum disorder is the world most common disorder in Children. In this study, I have to present 3 case reports of ASD children based on the assessment scale. The main course of treatment are Brami Nei as internal and Varmam as External therapy in the recommended dose as per Siddha pharmacopeia for 3 months. After 3 months, ASD children improve the cognitive skills and eye to eye contact Hyperactivity reduced well. Most of the formulation acting on psyche is ghee based. It is well established that the drugs to have its action on brain should have the capacity to cross the blood brain barrier and for the purpose ghee based Brahmi Nei is recommended for ASD in children. Manipulative therapy like Varma is to enhance the mind calming activity with sound sleep, good eye to eye contact and to reduce anxiety, hyperactivity. All the ingredients in both Internal medicines are herbal. So my attorney has to conclude the Siddha management therapy might be good and safest. It will be definitely efficacy in treating ASD children. Hence, Brami Nei as internal Varmam as External therapy may have a role to curing the ASD children.
RESUMO
Azhinjiathikashayam is a herbo mineral Siddha poly herbal formulation said for the management of Madhumegam (Type-2 Diabetes mellitus) in ancient Siddha literature. The study drug was subjected to estimate the therapeutic efficacy in Madhumegam patients. A well designed study protocol was approve by Institutional Ethics Committee and the clinical study was conducted as an open clinical trial in OPD/IPD of Ayothidoss pandithar Hospital of National Institute of Siddha Chennai. Based on the inclusion criteria 40 Madhumegam patients (Type -2 Diabetes mellitus) were enrolled in this study. Informed consent was obtained from each patient before study initiation. 60ml of Azhinjiathikashayam was administered orally before food twice a day for a period of 90 days and advised to follow the prescribed dietary regimen. All the baseline data, Laboratory investigations were recorded in the prescribed Case Report Form of each patient. Blood sugar level in fasting and postprandial was done once in 30 days and HbA1c was done before treatment (0th day) and after treatment (90th day). The clinical assessment was recorded once in 10 days. Paired ‘t’ test was used to test the significance of treatment using before and after treatment data on HbA1c, Clinical symptoms, Blood sugar fasting and postprandial. The level of significance probability 0.05 was used to test the treatment difference and the values are statistically significant. In this study there is statistically significant difference between before and after treatment on average HbA1c, average blood sugar of fasting and average clinical feature score (p < 0.0001).